Bone remodeling mechanisms in osteoporotic TgRANKL transgenic mouse models

Bone remodeling mechanisms in osteoporotic TgRANKL transgenic mouse models

Bibliographic Details
Main Authors:	Vagelis Rinotas, Panagiotis Nikolaou, Konstantinos Kritikos, Apostolos Papadopoulos, Lenka Plestilova, Astrid Jüngel, Martina Samiotaki, George Panayotou, Eleni Douni
Format:	Article
Language:	English
Published:	Elsevier 2020-10-01
Series:	Bone Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352187220302217

Similar Items

Transcriptomic analysis in the TgRANKL mouse model of osteoporosis reveals miRNAs as potent regulators of bone remodeling
by: Elisavet Ioannidou, et al.
Published: (2021-04-01)

RANKL promotes the expansion of mammary epithelial cells in osteoporotic TgRANKL mouse models
by: Anthi Kolokotroni, et al.
Published: (2020-10-01)

Investigating Denosumab discontinuation in the TgRANKL osteoporotic mouse model
by: Vagelis Rinotas, et al.
Published: (2021-04-01)

Investigating the pathophysiological role of RANKL in mammary gland density and oncogenesis in osteoporotic TgRANKL mice
by: Anthi Kolokotroni, et al.
Published: (2021-04-01)

Establishment of progesterone-induced mammary carcinogenesis in a humanized TgRANKL osteoporotic mouse model
by: Anthi Kolokotroni, et al.
Published: (2020-10-01)

New Insights for RANKL as a Proinflammatory Modulator in Modeled Inflammatory Arthritis
by: Maria Papadaki, et al.
Published: (2019-02-01)

Studying the role of RANKL in breast cancer and bone metastasis mouse models
by: Evi Gkikopoulou, et al.
Published: (2021-04-01)

In Silico Discovery of Plant-Origin Natural Product Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)
by: Georgia Melagraki, et al.
Published: (2018-07-01)

Cheminformatics-aided discovery of small-molecule Protein-Protein Interaction (PPI) dual inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL).
by: Georgia Melagraki, et al.
Published: (2017-04-01)

Bone resorption in mouse models of mitochondrial neurological diseases
by: Vasiliki-Iris Perivolidi, et al.
Published: (2020-10-01)

Sustained anti-osteoporotic action of risedronate compared to anti-RANKL antibody following discontinuation in ovariectomized mice
by: Toshinobu Omiya, et al.
Published: (2020-12-01)

Bisphosphonates Reduce Smoking-Induced Osteoporotic-Like Alterations by Regulating RANKL/OPG in an Osteoblast and Osteoclast Co-Culture Model
by: Sheng Zhu, et al.
Published: (2021-12-01)

Anti-osteoporotic activity of sialoglycoproteins isolated from the eggs of Carassius auratus by promoting osteogenesis and increasing OPG/RANKL ratio
by: Guanghua Xia, et al.
Published: (2015-05-01)

A study on OPG/RANK/RANKL axis in osteoporotic bile duct-ligated rats and the involvement of nitrergic and opioidergic systems
by: Amir Hossein Doustimotlagh, et al.
Published: (2018-01-01)

A splicing mutation in the novel mitochondrial protein DNAJC11 causes motor neuron pathology associated with cristae disorganization, and lymphoid abnormalities in mice.
by: Fotis Ioakeimidis, et al.
Published: (2014-01-01)

RANKL/RANK/OPG Pathway: A Mechanism Involved in Exercise-Induced Bone Remodeling
by: Mohammad Tobeiha, et al.
Published: (2020-01-01)

Role of RANKL-RANK/osteoprotegerin molecular complex in bone remodeling and its immunopathologic implications
by: Sarvraj Singh Kohli, et al.
Published: (2011-01-01)

Assessment of Serum sRANKL, sRANKL/OPG Ratio, and Other Bone Turnover Markers with the Estimated 10-Year Risk of Major and Hip Osteoporotic Fractures in Rheumatoid Arthritis: A Cross-Sectional Study
by: C. A. Nava-Valdivia, et al.
Published: (2021-01-01)

Characterization of Flavonoid Subgroups and Hydroxy Substitution by HPLC-MS/MS
by: Dimitrios Tsimogiannis, et al.
Published: (2007-03-01)

Role of TG2-Mediated SERCA2 Serotonylation on Hypoxic Pulmonary Vein Remodeling
by: Bo Liu, et al.
Published: (2020-02-01)

EFFECT OF INFLIXIMAB ON PARAMETERS OF REMODELING OF ARTERIAL BLOODSTREAM, RANKL AND OSTEOPROTEGERIN LEVELS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Larisa Aleksandrovna Knyazeva, et al.
Published: (2014-02-01)

RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives
by: Marco Infante, et al.
Published: (2019-01-01)

Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone.
by: Jinhu Xiong, et al.
Published: (2015-01-01)

The Role of the RANKL/RANK Axis in the Prevention and Treatment of Breast Cancer with Immune Checkpoint Inhibitors and Anti-RANKL
by: Aristofania Simatou, et al.
Published: (2020-10-01)

Inhibition of RANKL-Induced Osteoclastogenesis by Novel Mutant RANKL
by: Yuria Jang, et al.
Published: (2021-01-01)

RANKL Expression in Periodontal Disease: Where Does RANKL Come from?
by: Bin Chen, et al.
Published: (2014-01-01)

Identification of Immunoreactive Leishmania infantum Protein Antigens to Asymptomatic Dog Sera through Combined Immunoproteomics and Bioinformatics Analysis.
by: Maria Agallou, et al.
Published: (2016-01-01)

Immunization With a DNA Vaccine Cocktail Encoding TgPF, TgROP16, TgROP18, TgMIC6, and TgCDPK3 Genes Protects Mice Against Chronic Toxoplasmosis
by: Nian-Zhang Zhang, et al.
Published: (2018-06-01)

Anti-Osteoporotic Activity of an Edible Traditional Chinese Medicine Cistanche deserticola on Bone Metabolism of Ovariectomized Rats Through RANKL/RANK/TRAF6-Mediated Signaling Pathways
by: Bo Zhang, et al.
Published: (2019-11-01)

Evolved Gas Analysis Using Coupled TG-CG & TG-FTIR
by: Bradfield, Keith
Published: (1991)

TG-interacting factor 1 (Tgif1)-deficiency attenuates bone remodeling and blunts the anabolic response to parathyroid hormone
by: Hiroaki Saito, et al.
Published: (2019-03-01)

Glucocorticoids prolong the reversal-resorption phase delaying bone formation in intracortical remodelling compared to postmenopausal and osteoporotic women
by: Lisbeth Koch Thomsen, et al.
Published: (2021-04-01)

Mesenchymal Stromal Cell‐Seeded Biomimetic Scaffolds as a Factory of Soluble RANKL in Rankl‐Deficient Osteopetrosis
by: Ciro Menale, et al.
Published: (2019-01-01)

RANKL immunisation inhibits prostate cancer metastasis by modulating EMT through a RANKL-dependent pathway
by: Mineon Park, et al.
Published: (2021-06-01)

Characterization of Multimodal Silicas Using TG/DTG/DTA, Q-TG, and DSC Methods
by: Barbara Charmas, et al.
Published: (2018-12-01)

Decreases in the serum VLDL-TG/non-VLDL-TG ratio from early stages of chronic hepatitis C: alterations in TG-rich lipoprotein levels.
by: Motoi Nishimura, et al.
Published: (2011-01-01)

Biology of the RANKL-RANK-OPG System
by: Yongwon eChoi, et al.
Published: (2014-10-01)

Emerging functions of RANKL in lymphoid tissues
by: Christopher G Mueller, et al.
Published: (2012-09-01)

When all rankings do is rankle
by: Abd Razak, Dzulkifli
Published: (2009)

The Roadmap of RANKL/RANK Pathway in Cancer
by: Sandra Casimiro, et al.
Published: (2021-08-01)